(AOF) – Carmat fell 23.65% to 3.05 euros after its fundraising launched yesterday for a total gross amount of 16 million euros. The issue price of the new shares was set at 3 euros per share, representing a discount of 26.5% compared to the closing price of the Carmat share on May 15, 2024, i.e. 4.08 euros. It estimates that this new money will allow it to continue its operations until mid-August 2024, and in particular to continue the development of its production and sales, as well as its Eficas clinical trial in France.
Carmat emphasizes that this fundraising only partially finances its needs over the next 12 months, its additional financial need post-fundraising being estimated at around 30 million euros compared to 45 million previously.
The French company is therefore preparing to have to secure additional financing from the second half of 2024.
Existing shareholders Lohas (family office of Pierre Bastid) and Sante Holdings (family office of Antonino Ligresti), holding respectively 11.4% and 9.9% of the company’s capital before the fundraising, had committed to subscribe for an amount of 4 million each as part of the reserved offer. Allocated 100% as part of the reserved offer, these two shareholders see their total investment represent 50% of the total amount of the fundraising.
“This new funding is essential for Carmat, since it gives us the means to respond to the growing demand for Aeson, coming from French centers as part of the Eficas study, and from European hospitals carrying out commercial implementations.” , declares Stéphane Piat, general manager of Carmat. “Based on our achievements at the start of the year, we are confident of a substantial gradual increase in our sales over the coming months, to reach a turnover of “around 14 million euros in 2024”.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
